Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

December 09, 2022

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

News Daily News

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

July 15, 2022

Medtronic Recalls Batteries in Some HeartWare VAD Systems

News Daily News

Medtronic Recalls Batteries in Some HeartWare VAD Systems

June 23, 2022

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

News Daily News

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Michael O'Riordan

June 21, 2022

Medtronic’s HeartWare HVAD Recalled for Pump Weld Defect

News Daily News

Medtronic’s HeartWare HVAD Recalled for Pump Weld Defect

April 29, 2022

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

News Daily News

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

February 22, 2022

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.